Inovio Pharmaceuticals Inc (INO)
10.09
-0.07
(-0.69%)
USD |
NASDAQ |
Apr 25, 16:00
10.09
0.00 (0.00%)
After-Hours: 20:00
Inovio Pharmaceuticals Free Cash Flow (Quarterly): -26.28M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -26.28M |
| September 30, 2023 | -29.11M |
| June 30, 2023 | -32.34M |
| March 31, 2023 | -36.96M |
| December 31, 2022 | -36.51M |
| September 30, 2022 | -67.55M |
| June 30, 2022 | -51.25M |
| March 31, 2022 | -61.88M |
| December 31, 2021 | -38.53M |
| September 30, 2021 | -46.66M |
| June 30, 2021 | -78.67M |
| March 31, 2021 | -53.08M |
| December 31, 2020 | -52.18M |
| September 30, 2020 | -74.54M |
| June 30, 2020 | -27.19M |
| March 31, 2020 | -25.59M |
| December 31, 2019 | -13.85M |
| September 30, 2019 | -27.87M |
| June 30, 2019 | -24.01M |
| March 31, 2019 | -33.11M |
| December 31, 2018 | -17.62M |
| September 30, 2018 | -24.80M |
| June 30, 2018 | -19.48M |
| March 31, 2018 | -13.73M |
| December 31, 2017 | -14.83M |
| Date | Value |
|---|---|
| September 30, 2017 | -20.90M |
| June 30, 2017 | -21.76M |
| March 31, 2017 | -16.02M |
| December 31, 2016 | -14.97M |
| September 30, 2016 | -19.12M |
| June 30, 2016 | -15.99M |
| March 31, 2016 | -16.42M |
| December 31, 2015 | -7.600M |
| September 30, 2015 | 14.64M |
| June 30, 2015 | -9.668M |
| March 31, 2015 | -12.60M |
| December 31, 2014 | -8.247M |
| September 30, 2014 | -8.364M |
| June 30, 2014 | -8.854M |
| March 31, 2014 | -5.739M |
| December 31, 2013 | 0.9486M |
| September 30, 2013 | -5.889M |
| June 30, 2013 | -5.448M |
| March 31, 2013 | -5.170M |
| December 31, 2012 | -5.543M |
| September 30, 2012 | -6.050M |
| June 30, 2012 | -5.420M |
| March 31, 2012 | -5.534M |
| December 31, 2011 | -4.581M |
| September 30, 2011 | -5.284M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-78.67M
Minimum
Jun 2021
-13.85M
Maximum
Dec 2019
-42.32M
Average
-36.96M
Median
Mar 2023
Free Cash Flow (Quarterly) Benchmarks
| Cerus Corp | -15.18M |
| Stereotaxis Inc | -2.439M |
| Viemed Healthcare Inc | 5.352M |
| AIM ImmunoTech Inc | -9.956M |
| Protalix BioTherapeutics Inc | 3.345M |